By proceeding, you agree to our Terms of Use and Privacy Policy.
Dr. Thomas Miller is a seasoned drug hunter with 20 years of experience identifying and advancing drug candidates, including multiple molecules evaluated in clinical trials and the successful approval of Zolinza®.Over the course of his career, Dr.
Talks About #biotechnology #chemistry
Preferred Locations #Northamerica
The surge of clinical approvals in CKD and unprecedented use of surrogate endpoints in rare kidney diseases have catalysed a new era of complimentary therapies and precision medicine in drug development for kidney disease.
